Warning! GuruFocus detected
5 Severe warning signs
with INO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:INO Key Ratios
| Market Cap $ M | 70.41 |
| Enterprise Value $ M | -11.84 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.01 |
| Price/Sales | 240.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -3.99 |
| Beneish M-Score | -2.65 |
| 10-y EBITDA Growth Rate % | 2.20 |
| 5-y EBITDA Growth Rate % | 21.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.11 |
| EV-to-EBITDA | 0.11 |
| PEG | -- |
| Shares Outstanding M | 36.67 |
| Net Margin (%) | -49,199.08 |
| Operating Margin % | -51,559.17 |
| Pre-tax Margin (%) | -49,199.08 |
| Quick Ratio | 2.77 |
| Current Ratio | 2.77 |
| ROA % (ttm) | -81.98 |
| ROE % (ttm) | -119.02 |
| ROIC % (ttm) | -333.09 |
| Dividend Yield % | -- |
| Altman Z-Score | -22.91 |
INO Number of Guru Trades
INO Volume of Guru Trades
Gurus Latest Trades with NAS:INO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:INO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Inovio Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:INO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers